Thromb Haemost 2001; 86(05): 1156-1160
DOI: 10.1055/s-0037-1616044
Review Article
Schattauer GmbH

Prediction of Pulmonary Embolism Extent by Clinical Findings, D-dimer Level and Deep Vein Thrombosis Shown by Ultrasound

Cécile Galle
1   Division of Angiology and Hemostasis, Geneva, Switzerland
,
Jean-Pierre Papazyan
2   Division of Nuclear Medicine, Geneva, Switzerland
,
Marie-José Miron
1   Division of Angiology and Hemostasis, Geneva, Switzerland
,
Daniel Slosman
2   Division of Nuclear Medicine, Geneva, Switzerland
,
Henri Bounameaux
1   Division of Angiology and Hemostasis, Geneva, Switzerland
,
Arnaud Perrier
3   Medical Clinic 1, Geneva University Hospital, Geneva, Switzerland
› Author Affiliations
The study was supported in part by grant 32-36064.92 from the Swiss National Research Foundation, Bern, Switzerland, to A.P. and H.B. C.G. was the recipient of travel grants from the Fonds National de la Recherche Scientifique, Brussels, Belgium, and from the Université Libre de Bruxelles, Brussels, Belgium.
Further Information

Publication History

Received 04 January 2001

Accepted after revision 28 June 2001

Publication Date:
13 December 2017 (online)

Summary

Pulmonary embolism (PE) may encompass a wide spectrum of severity. To determine whether clinical findings, D-dimer (DD) concentration, and deep vein thrombosis (DVT) shown by lower-limb venous compression ultrasonography (US) might predict the scintigraphic extent of PE, we studied 104 hemodynamically stable consecutive outpatients with acute PE diagnosed by a high-probability ventilation-perfusion lung scan. Scintigraphic extent of PE was classified into three categories: perfusion defects corresponding to <30%, 30–50%, or >50% of the total lung area. Median respiratory and heart rates were found to be significantly related to the extent of PE. Higher median alveolar-arterial oxygen difference values were observed as the proportion of lung perfusion defects increased (>50% vs. <30%, 6.3 vs. 3.6 kPa, P <.0001). Median plasma DD concentration was 7950 g/L in patients with >50% perfusion defects compared to 2731 g/L in those with <30% defects (P = .0001). DD levels above 4000 g/L were associated to more extensive perfusion defects (>50% vs. <30% defects, OR 30; 95% CI 5.8–155). Finally, a proximal DVT was more likely among patients with larger perfusion defects (>50% vs. <30% defects, OR 4.5; 95% CI 1.5–13.6). In conclusion, clinical signs such as tachypnea and tachycardia, alveolar-arterial oxygen difference, plasma DD concentration, and presence of DVT on US are predictors of a larger PE, as assessed by the extent of perfusion defects on high probability lung scans.

 
  • References

  • 1 Stein PD, Henry JW. Clinical characteristics of patients with acute pulmonary embolism stratified according to their presenting syndromes. Chest 1997; 112: 974-9.
  • 2 Dalen JE, Haffajee CI, Alpert JS, Howe JP, Ockene IS, Paraskos JA. Pulmonary embolism, pulmonary hemorrhage and pulmonary infarction. N Engl J Med 1977; 296: 1431-5.
  • 3 Stein PD, Terrin ML, Hales CA. et al. Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Chest 1991; 100: 598-603.
  • 4 The PIOPED. Investigators. Value of the ventilation-perfusion scan in acute pulmonary embolism : results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990; 263: 2753-9.
  • 5 Perrier A, Bounameaux H, Morabia A. et al. Diagnosis of pulmonary embolism by a decision analysis-based strategy including clinical probability, D-dimer levels, and ultrasonography: a management study. Arch Intern Med 1996; 156: 531-6.
  • 6 Perrier A, Desmarais S, Miron MJ. et al. Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet 1999; 353: 190-5.
  • 7 Perrier A, Miron MJ, Desmarais S. et al. Using clinical evaluation and lung scan to rule out suspected pulmonary embolism: is it a valid option in patients with normal results of lower-limb venous compression ultrasonography?. Arch Intern Med 2000; 160: 512-6.
  • 8 Wells PS, Ginsberg JS, Anderson DR. et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med 1998; 129: 997-1005.
  • 9 Wells PS, Anderson DR, Rodger M. et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000; 83: 416-20.
  • 10 Wicki J, Perneger T, Junod AF, Bounameaux H, Perrier A. Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score. Arch Intern Med 2001; 161: 92-7.
  • 11 Goldhaber SZ, Haire WD, Feldstein ML. et al. Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right ventricular function and pulmonary perfusion. Lancet 1993; 341: 507-11.
  • 12 Wolfe MW, Lee RT, Feldstein ML, Parker JA, Come PC, Goldhaber SZ. Prognostic significance of right ventricular hypokinesis and perfusion lung scan defects in pulmonary embolism. Am Heart J 1994; 127: 1371-5.
  • 13 Kasper W, Konstantinides S, Geibel A. et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997; 30: 1165-71.
  • 14 Azarian R, Wartski M, Collignon MA. et al. Lung perfusion scans and hemodynamics in acute and chronic pulmonary embolism. J Nucl Med 1997; 38: 980-3.
  • 15 Ribeiro A, Juhlin-Dannfelt A, Brodin LA, Holmgren A, Jorfeldt L. Pulmonary embolism: relation between the degree of right ventricle overload and the extent of perfusion defects. Am Heart J 1998; 135: 868-74.
  • 16 Konstantinides S, Geibel A, Olschewski M. et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism. Circulation 1997; 96: 882-8.
  • 17 Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry. Lancet 1999; 353: 1386-9.
  • 18 Grifoni S, Olivotto I, Cecchini P. et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echo-cardiographic right ventricular dysfunction. Circulation 2000; 101: 2817-22.
  • 19 The Urokinase in Pulmonary Embolism Trial: a national cooperative study. Circulation 1973; 47 (suppl. II): 1-108.
  • 20 Stein PD, Goldhaber SZ, Henry JW. Alveolar-arterial oxygen gradient in the assessment of acute pulmonary embolism. Chest 1995; 107: 139-43.
  • 21 Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med 1978; 299: 926-30.
  • 22 Perrier A, Desmarais S, Goehring C. et al. D-dimer testing for suspected pulmonary embolism in outpatients. Am J Respir Crit Care Med 1997; 156: 492-6.
  • 23 Becker DM, Philbrick JT, Abbitt PL. Real-time ultrasonography for the diagnosis of lower extremity deep venous thrombosis: the wave of the future?. Arch Intern Med 1989; 149: 1731-4.
  • 24 Bounameaux H, Cirafici P, de Moerloose P. et al. Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism. Lancet 1991; 337: 196-200.
  • 25 Wicki J, Perrier A, Perneger T, Bounameaux H, Junod AF. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost 2000; 84: 548-52.